(Q37026681)

17 August 2017

In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

17 August 2017

0 references

author name string

Suresh Solapure

1

1 reference

17 August 2017

Neela Dinesh

2

1 reference

17 August 2017

Radha Shandil

3

1 reference

17 August 2017

Vasanthi Ramachandran

4

1 reference

17 August 2017

Sreevalli Sharma

5

1 reference

17 August 2017

Deepa Bhattacharjee

6

1 reference

17 August 2017

Samit Ganguly

7

1 reference

17 August 2017

Jitendar Reddy

8

1 reference

17 August 2017

Vijaykamal Ahuja

9

1 reference

17 August 2017

Vijender Panduga

10

1 reference

17 August 2017

Manish Parab

11

1 reference

17 August 2017

K G Vishwas

12

1 reference

17 August 2017

Naveen Kumar

13

1 reference

17 August 2017

Meenakshi Balganesh

14

1 reference

17 August 2017

V Balasubramanian

15

1 reference

17 August 2017

language of work or name

English

0 references

publication date

18 March 2013

1 reference

17 August 2017

5

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

17 August 2017

57

1 reference

17 August 2017

6

1 reference

17 August 2017

2506-2510

1 reference

Involvement of efflux pumps in the resistance to peptidoglycan synthesis inhibitors in Mycobacterium tuberculosis

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

A replication clock for Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Molecular cloning, overexpression and biochemical characterization of hypothetical beta-lactamases of Mycobacterium tuberculosis H37Rv

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Comparative review of the carbapenems

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Replication dynamics of Mycobacterium tuberculosis in chronically infected mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716166

Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23507276

12 December 2020

inferred from PubMed ID database lookup

Fast mouse PK (Fast PK): a rapid screening method to increase pharmacokinetic throughput in pre-clinical drug discovery

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23507276

12 December 2020

inferred from PubMed ID database lookup

The disposition and metabolism of meropenem in laboratory animals and man

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23507276

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.00023-13

1 reference

release_f6yyntssnjfizc6vqr3lqyxmne

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f6yyntssnjfizc6vqr3lqyxmne

24 November 2022

mapped directly with Wikidata item

1 reference

17 August 2017

PubMed publication ID

23507276

1 reference